Instituto de Investigación e Innovación en Ciencias Biomédicas (INiBICA)
Instituto de investigación
Ludwig Maximilian University of Munich
Múnich, AlemaniaPublicaciones en colaboración con investigadores/as de Ludwig Maximilian University of Munich (2)
2022
-
Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trials
Journal of Dermatological Treatment, Vol. 33, Núm. 1, pp. 266-277
2009
-
Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques
Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, Núm. 10, pp. 4012-4017